3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
21
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
7
Skin Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Uveal Melanoma
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pleural Effusion, Malignant
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Interventions
Cisplatin
32
Radiotherapy, Intensity-Modulated
21
Magnetic Resonance Spectroscopy
21
Radiotherapy
16
Specimen Handling
15
Radiation
14
Carboplatin
14
pembrolizumab
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Paclitaxel
8
Chemoradiotherapy
7
Biopsy
7
Taxes
6
Surveys and Questionnaires
6
Cetuximab
6
Nivolumab
5
Surgical Procedures, Operative
4
Observation
4
Fluorodeoxyglucose F18
4
Drug Therapy
4
Docetaxel
4
durvalumab
3
(225)Ac-DOTA-c(RGDyK)
3
toripalimab
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
Interleukin-2
×
1 year
×
Clear all
No trials found.